Literature DB >> 1662480

Detection of Epstein-Barr virus and human herpes virus type 6 in saliva from patients with lymphoproliferative diseases by the polymerase chain reaction.

I Saito1, S Nishimura, I Kudo, R I Fox, I Moro.   

Abstract

Direct detection of these viruses was made by using the PCR for amplifying viral DNA. In virtually all adults low levels of the herpesvirus can be detected. Therefore it is necessary to quantitate the amount of viral DNA, and a method to compare the plasmid containing the cloned target gene was used here. After 35 cycles of amplification, 10 copies of the viral DNA per 100 microliters saliva were detected. The PCR was used to detect increased levels of EBV and HHV-6 in saliva from patients with lymphoproliferative diseases, suggesting that these viruses may play a part in their pathogenesis. Viral detection by such highly sensitive methods as PCR may allow better monitoring of medication, as well as early detection of EBV- and HHV-6 related diseases that may arise in these patients. The great sensitivity of PCR and its ability to analyse very small samples make this technique most suitable for clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662480     DOI: 10.1016/0003-9969(91)90026-q

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  6 in total

Review 1.  The Epstein-Barr virus in autoimmunity.

Authors:  J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1995

2.  Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment.

Authors:  Craig S Miller; Sergei A Avdiushko; Richard J Kryscio; Robert J Danaher; Robert J Jacob
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Prognostic Value of Oral Epstein-Barr Virus DNA Load in Locoregionally Advanced Nasopharyngeal Carcinoma.

Authors:  Yong-Qiao He; Ting Zhou; Da-Wei Yang; Yi-Jing Jia; Lei-Lei Yuan; Wen-Li Zhang; Tong-Min Wang; Ying Liao; Wen-Qiong Xue; Jiang-Bo Zhang; Xiao-Hui Zheng; Xi-Zhao Li; Pei-Fen Zhang; Shao-Dan Zhang; Ye-Zhu Hu; Fang Wang; William C Cho; Jun Ma; Ying Sun; Wei-Hua Jia
Journal:  Front Mol Biosci       Date:  2022-01-13

4.  Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers.

Authors:  A Achiron; O Pinhas-Hamiel; Y Barak; L Doll; D Offen; R Djaldetti; G Frankel; B Shohat
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Low-incidence latent infection with variant B or roseola type human herpesvirus 6 in leukocytes of healthy adults.

Authors:  J Rajcáni; R Yanagihara; M S Godec; J W Nagle; M Kudelova; D M Asher
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.

Authors:  Yoshifumi Nagata; Hiroko Inoue; Koichi Yamada; Hiroyuki Higashiyama; Kenji Mishima; Yasuhiro Kizu; Ienaka Takeda; Fumio Mizuno; Yoshio Hayashi; Ichiro Saito
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.